2. Introduction
• Jaundice/ icterus, is a condition characterized by yellow discoloration of skin,
conjunctivae, and mucus membranes as a result of widespread tissue deposition of the
pigmented metabolite bilirubin.
• Normal total bilirubin level <1-1.5mg/dl
• Jaundice seen if Value exceeds 3mg/dl
• Bilirubin have high affinity for elastin rich tissues eg sclera, frenulum of tongue,so jaundice
appear first here .
4. • Bilirubin uptake to be mediated by liver specific bilirubin transporter (BT) by facilitating
diffusion process and by simple diffusion process
• Intracelluar binding to S-glutathion transferase to keep bilirubin in solution
• Conjugation with uridine diphosphate (UDP)-glucuronic acid done by the enzyme
bilirubin UDP-glucuronosyl transferase(B-UGT1A1) into monoglucuronide,diglucuronide
• Conjugated bilirubin transported into the bile canaliculus by an ATP-dependant export
pump eg.MRP-2,ABCC2
5. • Conjugated bilirubin in intestine converted to Urobilinogen by bacterial action which undergo
hepatic reuptake and partly renal elimination.
• Small amount secreted across sinusoidal membrane by MRP-3,that undergo renal elimination and
reuptake to hepatocyte by OAP1B1,OATP1B3
6. Differential diagnosis of jaundice
1. Isolated disorders of bilirubin metabolism-
Unconjugated hyperbilirubinemia-
• Increased bilirubin production-
• Haemolysis
• Ineffective erythropoiesis
• Blood transfusion
• Resorption of hematomas
•Decreased hepatocellular uptake-
• Drugs such as rifampicin
• Various cholecystography contrast agents
7. •Decreased conjugation –
• Gilbert’s syndrome, Crigler-Nazzer syndrome type1 and type2
• Physiological jaundice of newborn
• Drugs such as indinavir, atazanavir
Conjugated or mixed Hyperbilirubinemia-
Dubin johnson syndrome, Rotor’s syndrome
8. 2.Liver diseases-
a. Hepatocellular dysfunction –
Acute or subacute hepatocellular injury –
• Viral hepatitis
• Hepatotoxins such as ethanol, acetaminophen ,isoniazid , phenytoin
• Ischaemia such as in hypotension , vascular outflow obstruction
• Metabolic disorders such as Wilson’s ds, Reye’s syndrome
9. Chronic hepatocellular disease -
• Viral hepatitis
• Alcoholic liver disease
• Hepatotoxins such as ethanol , vinyl chloride , vitamin A
• Autoimmune hepatitis
• Metabolic disorders such as Hemochromatosis , Wilson's ds, NAFLD, a1-antitrypsin deficiency
10. b. Cholangiocytic injury-
• Primary biliary cirrhosis
• Graft-versus-host disease
• Drugs such as erythromycin, trimetholrim-sulfamethxazole,
• Cystic fibrosis
11. 3. Obstruction of the bile ducts
• Choledocholithiasis
• Primary sclerosing cholangitis
• Post surgical strictures
• Cholangiocarcinoma
• Pancreatic cancer
• Metastatic lymphadenopathy
• Ampullary carcinoma
• Pancreatitis
12. Diagnostic approach to jaundice
When clues are evaluated in the context of the physical findings and routine
laboratory tests , jaundice can be characterized correctly as obstructive or
nonobstructive.
13.
14. History
• H/O biliary surgery , fever, abdominal pain in right upper quadrant= Biliary obstruction with
cholangitis
• C/O anorexia, malaise, myalgia With H/O a known infectious exposure, injection drug use
,prior transfusions of blood products= suggestive of viral hepatitis
• Family H/O jaundice or liver disease= suggest hereditary hyperbilirubinaemia or genetic
liver disease
15. Physical Examination
• High fever and abdominal tenderness in RUQ=suggests cholangitis
• Palpable abdominal mass= Neoplastic cause of obstructive jaundice
• Silver coloured stool=Suggests ampullary neoplasms
• Ascites , splenomegaly and prominent abdominal veins= Suggests cirrhosis
• Abdominal scar in midline or RUQ=Prior biliary surgery
16. Essential laboratory studies in patient with jaundice
1. Serum total bilirubin, Direct bilirubin
2. Alkaline phosphatase (ALP)
3. AST/SGOT
4. ALT/SGPT
5. Complete blood count
6. Prothrombin time
17. Serum bilirubin
• Bilirubin is found in two fractions-
Unconjugated or indirect- Insoluble in water, bound to albumin
Conjugated bilirubin – water soluble ,excreted by kidney
• Normal value of total serum bilirubin -1-1.5 mg/dl
• If the direct acting fraction is <15% of total ,the bilirubin can be
considered to all be indirect.
18. Alkaline phosphatase (ALP)
• Increases in biliary obstruction and intrahepatic cholestasis
• Not a specific marker
• Elevation more than 4 times of normal is significant
• More specific markers for cholestasis are gamma glutamyl transpeptidase[GGT], 5’
Nucleotidase
19. Aminotransferase (ALT,AST)
• ALT, Cytosolic enzyme found predominantly in hepatocytes
• AST, Found in cytosol and mitochondria of parenchymal cells of liver
• Normal serum concentrations –10-40 IU/L
• Levels of upto 300 IU/L are nonspecific and may be found in any liver disorder
• Level >1000 IU/L occur almost exclusively in disorders associated with extensive hepatocellular
injury such as in viral hepatitis, ischaemic liver injury, toxins or drug induced liver injury.
20. • Predominantly elevation of serum aminotransferase activity in comparison with
alkaline phosphatase activity suggests that jaundice is the result of intrinsic
hepatocellular disease
• Pattern of the aminotransferase elevation can be helpful diagnostically
AST:ALT Ratio <1 is suggestive of chronic viral hepatitis and NAFLD
AST:ALT Ratio >2 is highly suggestive of alcoholic liver disease
21. Complete blood count
• Leucocytosis= Suggests Biliary tract obstruction or other inflammatory disorders
• Anaemia = Suggests haemolysis is the cause of bilirubin overload
• Thrombocytopenia=. Characteristic finding in cirrhosis results from reduced platelet production
from decrease hepatocyte synthesis of thrombopoietin or from increase of platelet consumption
from splenic sequestration
22. Prothrombin time
• Measure the plasma activities of coagulation factor 1,2,5,7,10 each of which is synthesized by
hepatocytes
• Prolongation of PT(and an associated increase in INR) can result from impaired hepatic synthesis
of these proteins and from deficiency of vitamin K which is required as a cofactor for essential
posttranslational modification of factor 2,7,9,10.
23. Efficient absorption of vitamin K by the small intestine requires an intact enterohepatic circulation
of bile salts(hence ,an unobstructed biliary tree).
Exogenous administration of vitamin K will generally normalize a prolonged PT in patients with
Obstructive jaundice and intrahepatic cholestasis but not in patients with liver disease caused by
hepatocellular injury.